| Serial Number | 99266049 |
| Word Mark | ALDAMA PHARMACEUTICALS, INC. |
| Filing Date | Thursday, July 3, 2025 |
| Status | 680 - APPROVED FOR PUBLICATION |
| Status Date | Friday, April 24, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
| Description of Mark | The mark consists of the wording "ALDAMA" above the words "PHARMACEUTICALS, INC." preceded by a circle and wave design running underneath the wording "PHARMACEUTICALS, INC." |
| Goods and Services | Custom manufacture of pharmaceuticals |
| NOT AVAILABLE | "PHARMACEUTICALS, INC." |
| Pseudo Mark | ALDAMA PHARMACEUTICALS INC |
| Goods and Services | Dietary supplements; Pharmaceutical preparations for the treatment of a wide variety of diseases, conditions and disorders, namely, infectious diseases, cardiovascular diseases, respiratory diseases, gastrointestinal diseases, metabolic and endocrine disorders, neurological diseases and disorders, psychiatric and mental health disorders, namely, anxiety disorder, depression disorder, substance use disorder, post-traumatic stress disorder, and bipolar disorder, autoimmune and inflammatory diseases, musculoskeletal disorders, dermatological diseases, oncological diseases, hematological disorders, renal and urological diseases, hepatic diseases, ophthalmic diseases, otic diseases, allergic diseases, immunological disorders, pain and pain related conditions, namely, chronic low back pain, osteoarthritis, migraine and chronic headache disorders, fibromyalgia, and neuropathic pain, sleep disorders, reproductive and sexual health disorders, hormonal disorders, nutritional deficiencies, genetic disorders, namely, down syndrome, Klinefelter syndrome, cystic fibrosis, sickle cell disease and Marfan syndrome, and chronic and acute medical conditions, namely, hypertension, type 2 diabetes, asthma, acute myocardial infarction, and pneumonia |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, July 3, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, July 3, 2025 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Aldama Pharmaceuticals, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Miami, FL 33122 US |
| Event Date | Event Description |
| Thursday, July 3, 2025 | NEW APPLICATION ENTERED |
| Thursday, July 3, 2025 | APPLICATION FILING RECEIPT MAILED |
| Monday, November 10, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, November 10, 2025 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Thursday, November 20, 2025 | ASSIGNED TO EXAMINER |
| Saturday, December 6, 2025 | NON-FINAL ACTION WRITTEN |
| Saturday, December 6, 2025 | NON-FINAL ACTION E-MAILED |
| Saturday, December 6, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, December 8, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, December 8, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, December 8, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, January 21, 2026 | EXAMINERS AMENDMENT -WRITTEN |
| Wednesday, January 21, 2026 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, January 21, 2026 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, January 21, 2026 | EXAMINER'S AMENDMENT ENTERED |
| Thursday, February 12, 2026 | NON-FINAL ACTION WRITTEN |
| Thursday, February 12, 2026 | NON-FINAL ACTION E-MAILED |
| Thursday, February 12, 2026 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, February 12, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, February 12, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, February 12, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, April 24, 2026 | FINAL REFUSAL WRITTEN |
| Friday, April 24, 2026 | FINAL REFUSAL E-MAILED |
| Friday, April 24, 2026 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Friday, April 24, 2026 | EXAMINERS AMENDMENT -WRITTEN |
| Friday, April 24, 2026 | EXAMINERS AMENDMENT E-MAILED |
| Friday, April 24, 2026 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Friday, April 24, 2026 | EXAMINER'S AMENDMENT ENTERED |
| Friday, April 24, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |